Total Anti-Infliximab
Confirms the immunogenicity by detecting total (free and bound) antibody against infliximab
AFIAS Total Anti-Infliximab detects the total (free and bound) antibody against infliximab in the patient’s blood. This helps to physicians for monitor and optimize the appropriate regimen of infliximab.
-
AFIAS
About Using Reagent
-
Sample Types
plasma, serum -
Reaction Time
22mins (AFIAS) -
Detection Range
AFIAS 8-250 AU/mL -
Indication
Therapeutic drug monitoring (TDM), Anti-drug antibody (ADA) detection, Immunogenicity
In Your Medical Field
AFIAS Total Anti-Infliximab test detects the total (free and bound) antibody against infliximab with a small amount of human serum or plasma in less than half an hour. This test provides information regarding the patients’ response towards the treatment of drug and based on result physicians can decide the appropriate infliximab regimen.